Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-7,078
Closed -$429K 760
2017
Q1
$429K Buy
+7,078
New +$429K 0.29% 104
2016
Q3
Sell
-640
Closed -$35K 747
2016
Q2
$35K Sell
640
-11
-2% -$585 0.04% 380
2016
Q1
$33K Sell
651
-493
-43% -$24.1K 0.04% 383
2015
Q4
$58K Buy
+1,144
New +$57.7K 0.06% 347

Other funds holding MRK

Invictus RG's MRK Position: Q2 2017 in Review

Invictus RG sold out of Merck (MRK) in Q2 2017, closing a stake of 7,078 shares — an estimated $429K sold.

Invictus RG first reported a position in MRK in Q4 2015 and held it in 4 quarters. The position peaked at $429K in Q1 2017. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Invictus RG reported no remaining Merck position as of Q2 2017 after selling out during the quarter.
  • Invictus RG sold 7,078 Merck shares in Q2 2017, an estimated $429K.
  • Invictus RG first reported a position in Merck in Q4 2015 and held it in 4 quarters.
  • Invictus RG's Merck position peaked at $429K in Q1 2017.
  • 1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Invictus RG's 13F filing for Q2 2017, filed 14 Aug 2017.